Year-end Sale % OFF 
Abstract
Norsertraline is in clinical trials for the treatment of central nervous system disorders. The synthesis depicted uses Candida antarctica lipase B together with the racemization catalyst B in a one-pot dynamic kinetic resolution of primary amines. The lipase selectively acylates (S)-A whilst the remaining (R)-A is racemized by a catalyst derived in situ from B.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
